Organization and Description of Business (Details Narrative) |
Apr. 16, 2021
$ / shares
shares
|
|---|---|
| Supera Pharmaceuticals Inc [Member] | Asset Purchase Agreement [Member] | |
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Stock issued during period, shares, acquisitions | shares | 33,937,909 |
| MyMD Pharmaceuticals (Florida), Inc [Member] | |
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Common stock, par value | $ 0.001 |
| Exchange ratio price per shares | $ 0.7718 |
| X | ||||||||||
- Definition Exchange ratio price per shares. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|